Novel Compounds Useful for Weight Control, Diabetes, and Anti-Cancer: Analogues of Beneficial Low-dose Toxicants (03KUMC308)
University of Kansas Medical Center Research, Inc., Office of Technology Transfer & Intellectual Property is pleased to offer visitors a new way to view KU technologies. At this time descriptions of KU technologies are accessible both through the links above and through the iBridge™ link below.
The iBridge™ Network provides the research community an additional channel through which to disseminate discoveries, research methods, and findings.
The Kauffman Innovation Network, an initiative launched by the Ewing Marion Kauffman Foundation, is piloting the iBridge™ application in the United States by licensing several universities' technology transfer offices to post research findings. KU is part of the pilot program.
The link to the KU page: http://www.ibridgenetwork.org/ku